rs140237315

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001165963.4(SCN1A):​c.5418G>A​(p.Glu1806Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0122 in 1,613,934 control chromosomes in the GnomAD database, including 240 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). The gene SCN1A is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.0096 ( 17 hom., cov: 32)
Exomes 𝑓: 0.012 ( 223 hom. )

Consequence

SCN1A
NM_001165963.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 1.99

Publications

7 publications found
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 2-165991857-C-T is Benign according to our data. Variant chr2-165991857-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93657.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.99 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00955 (1453/152142) while in subpopulation SAS AF = 0.0326 (157/4820). AF 95% confidence interval is 0.0284. There are 17 homozygotes in GnomAd4. There are 672 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1453 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001165963.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
NM_001165963.4
MANE Select
c.5418G>Ap.Glu1806Glu
synonymous
Exon 29 of 29NP_001159435.1P35498-1
SCN1A
NM_001202435.3
c.5418G>Ap.Glu1806Glu
synonymous
Exon 28 of 28NP_001189364.1P35498-1
SCN1A
NM_001353948.2
c.5418G>Ap.Glu1806Glu
synonymous
Exon 27 of 27NP_001340877.1P35498-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
ENST00000674923.1
MANE Select
c.5418G>Ap.Glu1806Glu
synonymous
Exon 29 of 29ENSP00000501589.1P35498-1
SCN1A
ENST00000303395.9
TSL:5
c.5418G>Ap.Glu1806Glu
synonymous
Exon 28 of 28ENSP00000303540.4P35498-1
SCN1A
ENST00000375405.7
TSL:5
c.5385G>Ap.Glu1795Glu
synonymous
Exon 26 of 26ENSP00000364554.3P35498-2

Frequencies

GnomAD3 genomes
AF:
0.00956
AC:
1454
AN:
152024
Hom.:
17
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00302
Gnomad AMI
AF:
0.0318
Gnomad AMR
AF:
0.0102
Gnomad ASJ
AF:
0.0277
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.0328
Gnomad FIN
AF:
0.000943
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0121
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0136
AC:
3412
AN:
251232
AF XY:
0.0155
show subpopulations
Gnomad AFR exome
AF:
0.00258
Gnomad AMR exome
AF:
0.00749
Gnomad ASJ exome
AF:
0.0288
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.00143
Gnomad NFE exome
AF:
0.0126
Gnomad OTH exome
AF:
0.0176
GnomAD4 exome
AF:
0.0125
AC:
18206
AN:
1461792
Hom.:
223
Cov.:
31
AF XY:
0.0135
AC XY:
9848
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.00230
AC:
77
AN:
33468
American (AMR)
AF:
0.00821
AC:
367
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0298
AC:
778
AN:
26132
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39696
South Asian (SAS)
AF:
0.0403
AC:
3478
AN:
86256
European-Finnish (FIN)
AF:
0.00172
AC:
92
AN:
53418
Middle Eastern (MID)
AF:
0.0428
AC:
247
AN:
5768
European-Non Finnish (NFE)
AF:
0.0110
AC:
12211
AN:
1111946
Other (OTH)
AF:
0.0158
AC:
953
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
1296
2593
3889
5186
6482
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
462
924
1386
1848
2310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00955
AC:
1453
AN:
152142
Hom.:
17
Cov.:
32
AF XY:
0.00903
AC XY:
672
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.00301
AC:
125
AN:
41534
American (AMR)
AF:
0.0102
AC:
155
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.0277
AC:
96
AN:
3470
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5154
South Asian (SAS)
AF:
0.0326
AC:
157
AN:
4820
European-Finnish (FIN)
AF:
0.000943
AC:
10
AN:
10606
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0121
AC:
821
AN:
67986
Other (OTH)
AF:
0.0156
AC:
33
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
71
142
212
283
354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0129
Hom.:
6
Bravo
AF:
0.00931
EpiCase
AF:
0.0169
EpiControl
AF:
0.0157

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
3
not provided (3)
-
-
1
Developmental and epileptic encephalopathy (1)
-
-
1
Epilepsy (1)
-
-
1
Generalized epilepsy with febrile seizures plus, type 2 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Migraine, familial hemiplegic, 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
10
DANN
Benign
0.48
PhyloP100
2.0
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140237315; hg19: chr2-166848367; COSMIC: COSV57676706; COSMIC: COSV57676706; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.